Transparency data: MHRA performance data for assessment of clinical trials and established medicines

⌂Back To Homepage Subscribe To RSS Feed

Medicines Healthcare Products Regulatory Agency

April 14

14:02 2023

Print This Article Share it With Friends

Created by Medicines Healthcare Products Regulatory Agency 0 comments

Clinical trials performance data

PDF, 383 KB, 12 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

MHRA established medicines performance data - January to March 2023

PDF, 277 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

Details

Information provided by the MHRA on current performance of regulatory decisions in the assessment of clinical trials and established medicines. This information is being provided to support companies to plan more effectively and with more certainty.

Contacting us

The performance data and timeframes published here are the most accurate indicators for the progress of assessments. Please review the most up-to-date performance metrics and timelines before contacting our Customer Experience Centre to check the status of your application(s).

MHRA clinical trials and established medicines performance data

Read more about the performance data and timelines for established medicines and performance data for clinical trials in the attached documents.

Published 14 April 2023

Your name:	Your email:
Comments:
Post my comment

GovWire